EUVIMEDEUVIMED entdecken
Vergleichsstudie

Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and Molds

Ahmed Gamal, Mohammed Elshaer, Lisa Long, Thomas S McCormick, Boni Elewski, Mahmoud A Ghannoum

Journal of the American Podiatric Medical Association · 2024

DOI: 10.7547/22-132 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of the American Podiatric Medical Association, 2024. Verfasst von Ahmed Gamal und 5 weiteren Autor:innen. Beteiligte Einrichtung: *Center for Medical Mycology, and Integrated Microbiome Core, Department of Dermatology, Case Western Reserve University, Cleveland, OH. Hauptthemen laut MEDLINE: Antifungal Agents, Itraconazole, Microbial Sensitivity Tests, Fluconazole. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Recently, an increasing number of resistant-to-terbinafine dermatophytosis cases have been reported. Thus, identifying an alternative antifungal agent that possesses broad-spectrum activity, including against resistant strains, is needed.

Methods

We compared the antifungal activity of efinaconazole with that of fluconazole, itraconazole, and terbinafine against clinical isolates of dermatophytes, Candida , and molds using in vitro assays. Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of each antifungal agent were quantified and compared. Susceptible and resistant clinical isolates of Trichophyton mentagrophytes (n = 16), Trichophyton rubrum (n = 43), Trichophyton tonsurans (n = 18), Trichophyton violaceum (n = 4), Candida albicans (n = 55), Candida auris (n = 30), Fusarium spp, Scedosporium spp, and Scopulariopsis spp (n = 15 for each) were tested.

Results

Efinaconazole was the most active antifungal agent tested against dermatophytes, with MIC 50 and MIC 90 (concentrations that inhibited 50% and 90% of strains tested, respectively) values of 0.002 and 0.03 µg/mL, respectively. Fluconazole, itraconazole, and terbinafine showed MIC 50 and MIC 90 values of 1 and 8 µg/mL, 0.03 and 0.25 µg/mL, and 0.03 and 16 µg/mL, respectively. Against Candida isolates, efinaconazole MIC 50 and MIC 90 values were 0.016 and 0.25 µg/mL, respectively, whereas fluconazole, itraconazole, and terbinafine had MIC 50 and MIC 90 values of 1 and 16 µg/mL, 0.25 and 0.5 µg/mL, and 2 and 8 µg/mL, respectively. Against various mold species, efinaconazole MIC values ranged from 0.016 to 2 µg/mL versus 0.5 to greater than 64 µg/mL for the comparators.

Conclusions

Efinaconazole showed superior potent activity against a broad panel of susceptible and resistant dermatophyte, Candida , and mold isolates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsItraconazoleMicrobial Sensitivity TestsFluconazoleTerbinafineCandidaDrug Resistance, FungalArthrodermataceaeTriazolesHumansNaphthalenesFungi

Substanzen

Antifungal AgentsItraconazoleFluconazoleTerbinafineefinaconazoleTriazolesNaphthalenes

Autor:innen und Institutionen

  • *Center for Medical Mycology, and Integrated Microbiome Core, Department of Dermatology, Case Western Reserve University, Cleveland, OH.
  • †Clinical Pathology Department, Mansoura University Faculty of Medicine, Mansoura, Egypt.
  • ‡Department of Dermatology, University of Birmingham, Birmingham, AL.
  • §University Hospitals Cleveland Medical Center, Cleveland, OH.

Zitieren

APA

Gamal, A., Elshaer, M., Long, L., McCormick, T. S., Elewski, B., & Ghannoum, M. A. (2024). Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and Molds. Journal of the American Podiatric Medical Association. https://doi.org/10.7547/22-132

Vancouver

Gamal A, Elshaer M, Long L, McCormick TS, Elewski B, Ghannoum MA. Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and Molds. Journal of the American Podiatric Medical Association. 2024. doi:10.7547/22-132

BibTeX
@article{Gamal2024,
  author = {Gamal, Ahmed and Elshaer, Mohammed and Long, Lisa and McCormick, Thomas S and Elewski, Boni and Ghannoum, Mahmoud A},
  title = {Antifungal Activity of Efinaconazole Compared with Fluconazole, Itraconazole, and Terbinafine Against Terbinafine- and Itraconazole-Resistant/Susceptible Clinical Isolates of Dermatophytes, Candida, and Molds},
  journal = {Journal of the American Podiatric Medical Association},
  year = {2024},
  doi = {10.7547/22-132}
}
Kostenlos starten →